Product Details
Mircera 75 mcg
Methoxy polyethylene glycol-epoetin beta75 mcg/0.3 mL
Solution for injection
ROA
Intravenous; Subcutaneous
Applicant Name
Roche Products Limited
NRN
A6-0106
Status
Active
Composition
Mircera 75 micrograms/0.3 mL solution for injection in pre-filled syringe. One pre-filled syringe contains 75 micrograms of Methoxy polyethylene glycol-epoetin beta* at a concentration of 250 micrograms/mL. The strength indicates the quantity of the protein moiety of the methoxy polyethylene glycol-epoetin beta molecule without consideration of the glycosylation. *Protein produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cells and covalently conjugated to a linear methoxy-polyethylene glycol (PEG). The potency of methoxy polyethene glycol-epoetin beta should not be compared to the potency of another pegylated or non-pegylated protein of the same therapeutic class Excipients: L-Methionine, Sodium sulphate anhydrous, Sodium dihydrogen phosphate monohydrate, Mannitol, Poloxamer 188, Hydrochloric acid, Sodium hydroxide (pH adjustment), Water for Injection (pH adjustment)
ATC Code/ATCvet Code
B03XA03
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
0.3 mL (75 µg) x 1’s (in prefilled syringe)
Product Description
Solution for injection in pre-filled syringe. The solution is clear and colourless to slightly yellowish
Manufacturer Name
Roche Diagnostics GmbH
Manufacturer Country
GERMANY
Approval Date
2023-07-03
Expiry Date
2028-07-02